APO RESEARCH · REPORT
Docetaxel
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
Product & engineering
Understand the product.
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
Selected research
Industry Growth & Trends
Global Docetaxel Industry Growth and Trends Forecast to 2032
Market perspective
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
China Docetaxel key players include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma, etc. Top four companies hold a share over 80%. In terms of product, 20 mg/ml is the largest segment, with a share nearly 85%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Docetaxel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Docetaxel market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Docetaxel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Docetaxel.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Docetaxel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Docetaxel Market by Company
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
Docetaxel Segment by Type
20 mg/ml
40 mg/ml
60 mg/ml
Docetaxel Segment by Application
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Others
Docetaxel Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Docetaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Docetaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Docetaxel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Docetaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Docetaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20 mg/ml
- 40 mg/ml
- 60 mg/ml
Applications
- Breast Cancer
- Prostate Cancer
- Non-small Cell Lung Cancer
- Others
Companies covered
- Hengrui Medicine
- Sanofi
- Qilu Pharma
- Shenzhen Main Luck Pharma
- Jiangsu Aosaikang Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Docetaxel Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Docetaxel Sales Estimates and Forecasts (2021-2032)
- 1.3 Docetaxel Market by Type
- 1.3.1 20 mg/ml
- 1.3.2 40 mg/ml
- 1.3.3 60 mg/ml
- 1.4 Global Docetaxel Market Size by Type
- 1.4.1 Global Docetaxel Market Size Overview by Type (2021-2032)
- 1.4.2 Global Docetaxel Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Docetaxel Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Docetaxel Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Docetaxel Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Docetaxel Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Docetaxel Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Docetaxel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Docetaxel Industry Trends
- 2.2 Docetaxel Industry Drivers
- 2.3 Docetaxel Industry Opportunities and Challenges
- 2.4 Docetaxel Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Docetaxel Revenue (2021-2026)
- 3.2 Global Top Players by Docetaxel Sales (2021-2026)
- 3.3 Global Top Players by Docetaxel Price (2021-2026)
- 3.4 Global Docetaxel Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Docetaxel Major Company Production Sites & Headquarters
- 3.6 Global Docetaxel Company, Product Type & Application
- 3.7 Global Docetaxel Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Docetaxel Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Docetaxel Players Market Share by Revenue in 2025
- 3.8.3 2025 Docetaxel Tier 1, Tier 2, and Tier 3
4 Docetaxel Regional Status and Outlook
- 4.1 Global Docetaxel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Docetaxel Historic Market Size by Region
- 4.2.1 Global Docetaxel Sales in Volume by Region (2021-2026)
- 4.2.2 Global Docetaxel Sales in Value by Region (2021-2026)
- 4.2.3 Global Docetaxel Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Docetaxel Forecasted Market Size by Region
- 4.3.1 Global Docetaxel Sales in Volume by Region (2027-2032)
- 4.3.2 Global Docetaxel Sales in Value by Region (2027-2032)
- 4.3.3 Global Docetaxel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Docetaxel by Application
- 5.1 Docetaxel Market by Application
- 5.1.1 Breast Cancer
- 5.1.2 Prostate Cancer
- 5.1.3 Non-small Cell Lung Cancer
- 5.1.4 Others
- 5.2 Global Docetaxel Market Size by Application
- 5.2.1 Global Docetaxel Market Size Overview by Application (2021-2032)
- 5.2.2 Global Docetaxel Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Docetaxel Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Docetaxel Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Docetaxel Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Docetaxel Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Docetaxel Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Docetaxel Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Hengrui Medicine
- 6.1.1 Hengrui Medicine Company Information
- 6.1.2 Hengrui Medicine Business Overview
- 6.1.3 Hengrui Medicine Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Hengrui Medicine Docetaxel Product Portfolio
- 6.1.5 Hengrui Medicine Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sanofi Docetaxel Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Qilu Pharma
- 6.3.1 Qilu Pharma Company Information
- 6.3.2 Qilu Pharma Business Overview
- 6.3.3 Qilu Pharma Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Qilu Pharma Docetaxel Product Portfolio
- 6.3.5 Qilu Pharma Recent Developments
- 6.4 Shenzhen Main Luck Pharma
- 6.4.1 Shenzhen Main Luck Pharma Company Information
- 6.4.2 Shenzhen Main Luck Pharma Business Overview
- 6.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Shenzhen Main Luck Pharma Docetaxel Product Portfolio
- 6.4.5 Shenzhen Main Luck Pharma Recent Developments
- 6.5 Jiangsu Aosaikang Pharma
- 6.5.1 Jiangsu Aosaikang Pharma Company Information
- 6.5.2 Jiangsu Aosaikang Pharma Business Overview
- 6.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jiangsu Aosaikang Pharma Docetaxel Product Portfolio
- 6.5.5 Jiangsu Aosaikang Pharma Recent Developments
7 North America by Country
- 7.1 North America Docetaxel Sales by Country
- 7.1.1 North America Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Docetaxel Sales by Country (2021-2026)
- 7.1.3 North America Docetaxel Sales Forecast by Country (2027-2032)
- 7.2 North America Docetaxel Market Size by Country
- 7.2.1 North America Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Docetaxel Market Size by Country (2021-2026)
- 7.2.3 North America Docetaxel Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Docetaxel Sales by Country
- 8.1.1 Europe Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Docetaxel Sales by Country (2021-2026)
- 8.1.3 Europe Docetaxel Sales Forecast by Country (2027-2032)
- 8.2 Europe Docetaxel Market Size by Country
- 8.2.1 Europe Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Docetaxel Market Size by Country (2021-2026)
- 8.2.3 Europe Docetaxel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Docetaxel Sales by Country
- 9.1.1 Asia-Pacific Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Docetaxel Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Docetaxel Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Docetaxel Market Size by Country
- 9.2.1 Asia-Pacific Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Docetaxel Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Docetaxel Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Docetaxel Sales by Country
- 10.1.1 South America Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Docetaxel Sales by Country (2021-2026)
- 10.1.3 South America Docetaxel Sales Forecast by Country (2027-2032)
- 10.2 South America Docetaxel Market Size by Country
- 10.2.1 South America Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Docetaxel Market Size by Country (2021-2026)
- 10.2.3 South America Docetaxel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Docetaxel Sales by Country
- 11.1.1 Middle East and Africa Docetaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Docetaxel Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Docetaxel Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Docetaxel Market Size by Country
- 11.2.1 Middle East and Africa Docetaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Docetaxel Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Docetaxel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Docetaxel Value Chain Analysis
- 12.1.1 Docetaxel Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Docetaxel Production Mode & Process
- 12.2 Docetaxel Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Docetaxel Distributors
- 12.2.3 Docetaxel Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst